SKI Market

Indian Indices

Nifty

24,565.35 -203.00
(-0.82%)

Sensex

80,599.91 -585.67
( -0.72%)

Bank Nifty

55,617.60 -344.35
( -0.62%)

Nifty IT

34,649.60 -652.00
( -1.85%)

Global Indices

Nasdaq

44,167.41 -314.88
(-0.71%)

Dow Jones

6,364.11 -19.79
(-0.31%)

Hang Seng

40,837.80 -232.02
(-0.56%)

Nikkei 225

9,132.81 -4.13
(-0.05%)

Forex

USD-INR

87.43 0.51
(0.59%)

EUR-INR

100.57 0.11
(0.10%)

GBP-INR

116.43 0.45
(0.39%)

JPY-INR

0.59 0.00
(0.53%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Panacea Biotec Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

531349

INE922B01023

51.2589797

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PANACEABIO

2470.55

EPS(TTM)

Face Value()

Div & Yield %

Back

HFCL reports consolidated net loss of Rs 32.24 crore in the June 2025 quarter

Jul 25,2025

Net loss of HFCL reported to Rs 32.24 crore in the quarter ended June 2025 as against net profit of Rs 111.30 crore during the previous quarter ended June 2024. Sales declined 24.80% to Rs 871.02 crore in the quarter ended June 2025 as against Rs 1158.24 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	871.02	1158.24	-25
OPM %	3.26	15.08	-
PBDT	-12.50	142.86	PL
PBT	-44.70	118.79	PL
NP	-32.24	111.30	PL

24,565.35 -203.00 (-0.82%)

80,599.91 -585.67 ( -0.72%)

55,617.60 -344.35 ( -0.62%)

34,649.60 -652.00 ( -1.85%)

44,167.41 -314.88 (-0.71%)

6,364.11 -19.79 (-0.31%)

40,837.80 -232.02 (-0.56%)

9,132.81 -4.13 (-0.05%)

87.43 0.51 (0.59%)

100.57 0.11 (0.10%)

116.43 0.45 (0.39%)

0.59 0.00 (0.53%)